Trial Profile
Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion, a Randomized Controlled Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2022
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma; Nasal congestion
- Focus Therapeutic Use
- 30 Aug 2016 Status changed from recruiting to discontinued as investigational drug no longer available.
- 26 Mar 2012 New trial record